Publications

Select publications 

For more publications, please view the member profiles.

• Anwari P, Burnett E, Chavers TP, Samsor A, Safi H, Safi N, Clark AD, Parashar UD, Tate JE. Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018-2022. Vaccine, 42(8):2059-2064, 2024. https://doi.org/10.1016/j.vaccine.2024.02.057  

• Auzenbergs M, Maure C, Kang H, Brady O, Sahastrabuddhe S, Abbas K. Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: stakeholder analysis. PLoS Neglected Tropical Diseases, 18(4):e0012075, 2024. https://dx.doi.org/10.1371/journal.pntd.0012075 

• Kang H, Auzenbergs M, Clapham H, Maure C, Kim JH, Salje H, Taylor CG, Lim A, Clark A, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. The Lancet Infectious Diseases, S1473-3099(23)00810-1, 2024. https://doi.org/10.1016/S1473-3099(23)00810-1   

• Li J, Chen S, Asturias E, Tang S, Cui F. Promoting higher-valent pediatric combination vaccines in China: challenges and recommendations for action. Infectious Diseases of Poverty, 13(1):12, 2024. https://doi.org/10.1186/s40249-024-01181-9 

• Giannini F, Cannon JW, Cadarette D, Bloom DE, Moore HC, Carapetis J, Abbas K. Modeling the potential health impact of prospective Strep A vaccines. NPJ Vaccines, 8(1):90, 2023. https://doi.org/10.1038/s41541-023-00668-0  

• Kim C, Holm M, Frost I, Hasso-Agopsowicz M, Abbas K. Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study. BMJ Global Health, 8(7):e011341, 2023. https://doi.org/10.1136/bmjgh-2022-011341 

• Kobayashi T, Tomoi H, Nishina Y, Harada K, Tanaka K, Sasaki S, Inaba K, Mitaka H, Takahashi H, Passanante A, Lau EHY, Naito T, Larson H, Wu J, Lin L, Yamada Y. Effect of a mobile app chatbot and an interactive small-group webinar on COVID-19 vaccine intention and confidence in Japan: a randomised controlled trial. BMJ Global Health, 8(5):e010370, 2023. https://doi.org/10.1136/bmjgh-2022-010370 

• Khongyot T, Moriyasu T. Invasive Pneumococcal Disease diminish during the onset of COVID-19 in Japan between 2019 and 2022. International Journal of Infectious Diseases, 122:307-309, 2022. https://doi.org/10.1016/j.ijid.2022.05.064 

• Hasan AZ, Kumar MS, Prosperi C, Thangaraj JWV, Sabarinathan R, Saravanakumar V, Duraiswamy A, Kaduskar O, Bhatt V, Deshpande GR, Ullas PT, Sapkal GN, Sangal L, Mehendale SM, Gupta N, Moss WJ, Hayford K, Murhekar MV; IMRVI Study Group. Implementing serosurveys in India: experiences, lessons learned, and recommendations. American Journal of Tropical Medicine and Hygiene, 105(6):1608-1617, 2021. https://doi.org/10.4269/ajtmh.21-0401 

• Mogasale VV, Saldanha P, Pai V, Rekha PD, Mogasale V. A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. Scientific Reports, Mar 4;11(1):5116, 2021. https://doi.org/10.1038/s41598-021-84293-8